Insider Selling: Castlight Health, inc. (CSLT) Insider Sells 23,800 Shares of Stock

Castlight Health, inc. (NYSE:CSLT) insider Giovanni M. Colella sold 23,800 shares of the stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $4.05, for a total transaction of $96,390.00. Following the sale, the insider now owns 78,906 shares of the company’s stock, valued at $319,569.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Castlight Health, inc. (NYSE:CSLT) traded down 6.41% during midday trading on Thursday, reaching $3.65. 1,076,299 shares of the company’s stock were exchanged. Castlight Health, inc. has a 12-month low of $3.05 and a 12-month high of $5.50. The company’s market cap is $480.66 million. The firm has a 50-day moving average price of $4.23 and a 200 day moving average price of $3.80.

Castlight Health, inc. (NYSE:CSLT) last posted its quarterly earnings results on Wednesday, August 2nd. The software maker reported ($0.07) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.02. Castlight Health, inc. had a negative net margin of 42.54% and a negative return on equity of 36.30%. The company had revenue of $32.10 million during the quarter, compared to analyst estimates of $31.14 million. During the same period in the prior year, the business posted ($0.11) EPS. The firm’s revenue was up 36.0% compared to the same quarter last year. On average, analysts expect that Castlight Health, inc. will post ($0.25) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: Castlight Health, inc. (CSLT) Insider Sells 23,800 Shares of Stock” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://sportsperspectives.com/2017/08/17/insider-selling-castlight-health-inc-cslt-insider-sells-23800-shares-of-stock.html.

Several equities research analysts have recently weighed in on CSLT shares. Zacks Investment Research cut shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Thursday, April 27th. Dougherty & Co started coverage on shares of Castlight Health, inc. in a research report on Wednesday, May 10th. They set a “buy” rating and a $5.50 price objective for the company. Morgan Stanley cut shares of Castlight Health, inc. from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $4.00 to $3.75 in a research report on Friday, May 12th. ValuEngine cut shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Friday, May 19th. Finally, Chardan Capital started coverage on shares of Castlight Health, inc. in a research report on Tuesday, June 6th. They set a “buy” rating and a $4.50 price objective for the company. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $4.57.

A number of hedge funds and other institutional investors have recently modified their holdings of CSLT. Geode Capital Management LLC increased its position in shares of Castlight Health, inc. by 2.7% in the first quarter. Geode Capital Management LLC now owns 306,367 shares of the software maker’s stock worth $1,118,000 after buying an additional 8,057 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Castlight Health, inc. by 7.6% in the first quarter. Vanguard Group Inc. now owns 2,673,760 shares of the software maker’s stock worth $9,760,000 after buying an additional 189,359 shares during the last quarter. Concourse Capital Management LLC bought a new position in shares of Castlight Health, inc. during the first quarter worth about $233,000. Royce & Associates LP increased its position in shares of Castlight Health, inc. by 244.7% in the first quarter. Royce & Associates LP now owns 463,709 shares of the software maker’s stock worth $1,693,000 after buying an additional 329,188 shares during the last quarter. Finally, TIAA CREF Investment Management LLC increased its position in shares of Castlight Health, inc. by 2.1% in the first quarter. TIAA CREF Investment Management LLC now owns 108,032 shares of the software maker’s stock worth $394,000 after buying an additional 2,210 shares during the last quarter. 40.17% of the stock is currently owned by institutional investors and hedge funds.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply